VIP
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
Vasoactive intestinal peptide (VIP) is an endogenous 28-amino-acid neuropeptide of the secretin/glucagon superfamily, acting through the VPAC1 and VPAC2 receptors. Research describes broad signaling roles including smooth-muscle relaxation, immune modulation, and neuroendocrine regulation.
VIP biology is well documented in physiology; therapeutic applications of exogenous VIP remain investigational.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 2013;45(1):25-39.
- Iwasaki M, et al. VIP and PACAP: roles in neuroprotection and metabolism. Journal of Molecular Neuroscience. 2019;68(3):378-385.
- Said SI. Vasoactive intestinal peptide. Journal of Endocrinological Investigation. 1986;9(2):191-200.
Trademarks & attribution
Vasoactive intestinal peptide is an endogenous neuropeptide with no registered consumer pharmaceutical trademark for this presentation. Supplied as reference material only.
